Thermo Fisher Scientific Announces Membership of the Pistoia Alliance

Cross-industry collaboration will accelerate digital solutions and support R&D innovation by customers CARLSBAD, Calif., Nov. 13, 2019 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, has become a member of the Pistoia Alliance, a global, not-for-profit alliance of life science companies, vendors, publishers and academic groups working to lower barriers to innovation in... Read more

Strengthening Our Portfolio of Transmission Electron Microscopes for the Pharmaceutical Industry Through Investment to Vironova AB

Hitachi High-Technologies Corporation (TSE:8036/Hitachi High-Tech) have undertaken a third-party allotment of shares (this capital alliance) with Vironova AB (Main office: Stockholm, Sweden /CEO: Mohammed Homman/Vironova), who develop and sell analysis software for transmission electron microscopes (TEM) along with carrying out contract analysis for pharmaceutical companies. Through this capital alliance, we aim to jointly develop TEM... Read more

Xylem to participate in the Cowen 4th Annual Industrial Innovation & Technology Summit

RYE BROOK, N.Y.–(BUSINESS WIRE)–Nov. 6, 2019– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that its Vice President, Treatment, Amanda Gwyther will present at 9:40AM Eastern Standard time at the Cowen 4th Annual Industrial Innovation & Technology Summit at the Maxwell Hotel... Read more

Roche to present new data highlighting breadth of haematology portfolio and pipeline at the American Society of Hematology 2019 Annual Meeting

Basel, 06 November 2019 Roche to present new data highlighting breadth of haematology portfolio and pipeline at the American Society of Hematology 2019 Annual Meeting Ten Roche medicines will be featured in more than 70 abstracts and 21 oral presentations, across a range of 15 blood cancers and non-malignant haematological conditions New data for CD20-CD3... Read more

Brooks to Participate in the Stephens Nashville 2019 Investment Conference

CHELMSFORD, Mass., Nov. 5, 2019 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the Stephens Nashville 2019 Investment Conference at the Omni Nashville hotel on Thursday November 14th at 1:45pm CST (2:45pm EST).   Lindon Robertson, EVP and CFO, will take part in a 45-minute session with Q&A which will... Read more

SIEMENS HEALTHINEERS ENTERS INTO LICENSE AND SUPPLY ARRANGEMENT WITH QUANTERIX FOR ACCESS TO NEUROFILAMENT LIGHT (NF-L) ANTIBODIES TO DEVELOP NF-L ASSAYS

NOVEMBER 04, 2019 BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into a licensing and supply arrangement with Siemens Healthineers for access to Quanterix’ proprietary Nf-L antibodies, which were recently acquired from UmanDiagnostics. Access to the Nf-L antibodies will allow Siemens... Read more

Mesa Labs Acquires Gyros Protein Technologies

LAKEWOOD, Colo., Oct. 31, 2019 (GLOBE NEWSWIRE) —  Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a diversified supplier of quality control instruments and consumables to highly regulated markets today announced the acquisition of Gyros Protein Technologies Holding AB (“GPT”).  GPT is headquartered in Uppsala, Sweden and is a leading provider of Immunoassay... Read more

PerkinElmer Genomics’ Clinical Labs in U.S. and Malaysia to Process Samples with Vanadis Fully Automated NIPT Platform

Technology Provides Pregnant Women Widespread NIPT Access WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 29, 2019– PerkinElmer, Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that PerkinElmer Genomics will begin processing samples with the Vanadis® fully automated non-invasive prenatal testing (NIPT) system at its state-of-the-art CLIA and CAP-certified clinical laboratory in Pittsburgh,... Read more

Sartorius Stedim Biotech signs agreement to acquire select Danaher Life Science platform businesses

Aubagne, October 21, 2019 The proposed transaction is part of the sale of a larger portfolio of businesses from Danaher to SSB’s major shareholder Sartorius Group Includes chromatography hardware and resins, and microcarriers (SoloHill) businesses Complements SSB’s strong position in the fast-growing bioprocessing market Agreement is subject to acquisition of the GE Biopharma business by... Read more